Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.

Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Zaborsky, N; Steiner, M; Weis, S; Greil, R; Egle, A; Melchardt, T. ESMO Open. 2021 Feb;6(1):100012. doi: 10.1016/j.esmoop.2020.100012. Epub 2021 Jan 4.

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.

Pleyer, L; Leisch, M; Kourakli, A; Padron, E; Maciejewski, JP; Xicoy Cirici, B; Kaivers, J; Ungerstedt, J; Heibl, S; Patiou, P; Hunter, AM; Mora, E; Geissler, K; Dimou, M; Jimenez Lorenzo, MJ; Melchardt, T; Egle, A; Viniou, AN; Patel, BJ; Arnan, M; Valent, P; Roubakis, C; Bernal Del Castillo, T; Galanopoulos, A; Calabuig Muñoz, M; Bonadies, N; Medina de Almeida, A; Cermak, J; Jerez, A; Montoro, MJ; Cortés, A; Avendaño Pita, A; Lopez Andrade, B; Hellstroem-Lindberg, E; Germing, U; Sekeres, MA; List, AF; Symeonidis, A; Sanz, GF; Larcher-Senn, J; Greil, R. Lancet Haematol. 2021 Feb;8(2):e135-e148. doi: 10.1016/S2352-3026(20)30374-4.

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.

Dubsky, P; Vant Veer, L; Gnant, M; Rudas, M; Bago-Horvath, Z; Greil, R; Lujinovic, E; Buresch, J; Rinnerthaler, G; Hulla, W; Moinfar, F; Egle, D; Herz, W; Dreezen, C; Frantal, S; Filipits, M. ESMO Open. 2021 Feb;6(1):100006. doi: 10.1016/j.esmoop.2020.100006. Epub 2020 Dec 31.

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.

Gassner, FJ; Zaborsky, N; Buchumenski, I; Levanon, EY; Gatterbauer, M; Schubert, M; Rauscher, S; Hebenstreit, D; Nadeu, F; Campo, E; Egle, A; Greil, R; Geisberger, R. Leukemia. 2021 Apr;35(4):1053-1063. doi: 10.1038/s41375-020-0995-6. Epub 2020 Jul 30.

Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.

Huemer, F; Rinnerthaler, G; Jörg, B; Morre, P; Stegbuchner, B; Proksch, E; Fleimisch, S; Oberkofler, H; Kremser, I; Greil, R; Egle, A. Geroscience. 2021 Apr 10;1-21. doi: 10.1007/s11357-021-00352-y. Online ahead of print.

Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in ad-vanced or metastatic gastric or gastroesophageal junction adenocarci-noma.

Schlintl, V; Huemer, F; Greil, R; Weiss, L. J Gastrointest Oncol. 2021 Apr;12(2):906-909. doi: 10.21037/jgo-20-230.

Protein kinase C-β-dependent changes in the glucose metabolism of bo-ne marrow stromal cells of chronic lymphocytic leukemia.

von Heydebrand, F; Fuchs, M; Kunz, M; Voelkl, S; Kremer, AN; Oostendorp, RAJ; Wilke, J; Leitges, M; Egle, A; Mackensen, A; Lutzny-Geier, G. Stem Cells. 2021 Jun;39(6):819-830. doi: 10.1002/stem.3352. Epub 2021 Feb 17.

Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).

Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dan-dachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R. BREAST CARE. 2021; DOI: 10.1159/000512467.

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia develo-pment by enhanced tumor immune evasion.

Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A. Blood. 2019 Nov 14;134(20):1717-1729. doi: 10.1182/blood.2019000973.

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria. A cross-sectional multicentre observational study.

Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H. memo – Magazine of European Medical Oncology volume 12, pages290–296(2019).